vs
MIMEDX GROUP, INC.（MDXG）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
MIMEDX GROUP, INC.的季度营收约是REPUBLIC BANCORP INC的1.3倍（$118.1M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs 12.9%，领先11.3%），MIMEDX GROUP, INC.同比增速更快（27.1% vs 5.3%），过去两年MIMEDX GROUP, INC.的营收复合增速更高（18.1% vs -11.5%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
MDXG vs RBCAA — 直观对比
营收规模更大
MDXG
是对方的1.3倍
$94.3M
营收增速更快
MDXG
高出21.8%
5.3%
净利率更高
RBCAA
高出11.3%
12.9%
两年增速更快
MDXG
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $94.3M |
| 净利润 | $15.2M | $22.8M |
| 毛利率 | 83.9% | — |
| 营业利润率 | 17.8% | 29.3% |
| 净利率 | 12.9% | 24.2% |
| 营收同比 | 27.1% | 5.3% |
| 净利润同比 | 104.2% | 20.0% |
| 每股收益（稀释后） | $0.10 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGRBCAA
| Q4 25 | $118.1M | $94.3M | ||
| Q3 25 | $113.7M | $93.5M | ||
| Q2 25 | $98.6M | $93.8M | ||
| Q1 25 | $88.2M | $135.8M | ||
| Q4 24 | $92.9M | $89.5M | ||
| Q3 24 | $84.1M | $88.1M | ||
| Q2 24 | $87.2M | $86.9M | ||
| Q1 24 | $84.7M | $120.3M |
净利润MDXGRBCAA
| Q4 25 | $15.2M | $22.8M | ||
| Q3 25 | $16.7M | $29.7M | ||
| Q2 25 | $9.6M | $31.5M | ||
| Q1 25 | $7.0M | $47.3M | ||
| Q4 24 | $7.4M | $19.0M | ||
| Q3 24 | $8.1M | $26.5M | ||
| Q2 24 | $17.6M | $25.2M | ||
| Q1 24 | $9.3M | $30.6M |
毛利率MDXGRBCAA
| Q4 25 | 83.9% | — | ||
| Q3 25 | 83.5% | — | ||
| Q2 25 | 81.1% | — | ||
| Q1 25 | 81.2% | — | ||
| Q4 24 | 81.8% | — | ||
| Q3 24 | 81.8% | — | ||
| Q2 24 | 83.0% | — | ||
| Q1 24 | 84.7% | — |
营业利润率MDXGRBCAA
| Q4 25 | 17.8% | 29.3% | ||
| Q3 25 | 19.5% | 40.4% | ||
| Q2 25 | 12.5% | 43.0% | ||
| Q1 25 | 9.4% | 44.1% | ||
| Q4 24 | 11.9% | 25.8% | ||
| Q3 24 | 13.3% | 38.4% | ||
| Q2 24 | 26.9% | 37.0% | ||
| Q1 24 | 15.6% | 32.2% |
净利率MDXGRBCAA
| Q4 25 | 12.9% | 24.2% | ||
| Q3 25 | 14.7% | 31.8% | ||
| Q2 25 | 9.8% | 33.5% | ||
| Q1 25 | 8.0% | 34.8% | ||
| Q4 24 | 8.0% | 21.2% | ||
| Q3 24 | 9.6% | 30.1% | ||
| Q2 24 | 20.2% | 29.0% | ||
| Q1 24 | 10.9% | 25.4% |
每股收益（稀释后）MDXGRBCAA
| Q4 25 | $0.10 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $0.06 | — | ||
| Q1 25 | $0.05 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.12 | — | ||
| Q1 24 | $0.06 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $220.0M |
| 总债务越低越好 | $18.0M | — |
| 股东权益账面价值 | $256.5M | $1.1B |
| 总资产 | $342.7M | $7.0B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资MDXGRBCAA
| Q4 25 | $166.1M | $220.0M | ||
| Q3 25 | $142.1M | $484.2M | ||
| Q2 25 | $118.9M | $484.8M | ||
| Q1 25 | $106.4M | $793.0M | ||
| Q4 24 | $104.4M | $432.2M | ||
| Q3 24 | $88.8M | $530.9M | ||
| Q2 24 | $69.0M | $400.1M | ||
| Q1 24 | $48.5M | $546.4M |
总债务MDXGRBCAA
| Q4 25 | $18.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $19.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDXGRBCAA
| Q4 25 | $256.5M | $1.1B | ||
| Q3 25 | $238.9M | $1.1B | ||
| Q2 25 | $216.6M | $1.1B | ||
| Q1 25 | $202.8M | $1.0B | ||
| Q4 24 | $193.1M | $992.0M | ||
| Q3 24 | $181.0M | $979.7M | ||
| Q2 24 | $168.0M | $955.4M | ||
| Q1 24 | $155.7M | $935.6M |
总资产MDXGRBCAA
| Q4 25 | $342.7M | $7.0B | ||
| Q3 25 | $319.0M | $7.0B | ||
| Q2 25 | $291.1M | $7.0B | ||
| Q1 25 | $270.4M | $7.1B | ||
| Q4 24 | $263.9M | $6.8B | ||
| Q3 24 | $243.9M | $6.7B | ||
| Q2 24 | $230.2M | $6.6B | ||
| Q1 24 | $221.7M | $6.9B |
负债/权益比MDXGRBCAA
| Q4 25 | 0.07× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | — | 7.5% |
| 现金转化率经营现金流/净利润 | 1.64× | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流MDXGRBCAA
| Q4 25 | $25.0M | $168.2M | ||
| Q3 25 | $29.3M | $33.3M | ||
| Q2 25 | $14.4M | $8.4M | ||
| Q1 25 | $5.3M | $93.2M | ||
| Q4 24 | $18.8M | $149.0M | ||
| Q3 24 | $19.6M | $51.3M | ||
| Q2 24 | $21.8M | $4.0M | ||
| Q1 24 | $6.0M | $71.2M |
自由现金流MDXGRBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率MDXGRBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度MDXGRBCAA
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率MDXGRBCAA
| Q4 25 | 1.64× | 7.37× | ||
| Q3 25 | 1.75× | 1.12× | ||
| Q2 25 | 1.50× | 0.27× | ||
| Q1 25 | 0.75× | 1.97× | ||
| Q4 24 | 2.53× | 7.84× | ||
| Q3 24 | 2.42× | 1.93× | ||
| Q2 24 | 1.24× | 0.16× | ||
| Q1 24 | 0.65× | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
RBCAA
暂无分部数据
